Select Topic:
Browse by Series:

Platinum Sensitivity and PARP Inhibition in Ovarian Cancer

Insights From: Angeles Alvarez Secord, MD, Duke University Medical Center; Michelle Berke
Published: Thursday, Dec 28, 2017

Slider Left
Slider Right
View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: The Expanding Role of PARP Inhibitors in the Treatment of Ovarian Cancers – Current Strategies and Future DirectionJan 30, 20181.5
Clinical Vignette Series: 34th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®Feb 28, 20182.0
Publication Bottom Border
Border Publication
x